RELATLIMAB

UNII:	AF75XOF6W3
Formula:
Preferred Substance Name:	RELATLIMAB

1673516-98-7
BMS-986016
BMS-986213 COMPONENT RELATLIMAB
IMMUNOGLOBULIN G4, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN HEAVY CHAIN), DISULFIDE WITH HUMAN LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE 3 PROTEIN (LAG-3, PROTEIN FDC, CD223 ANTIGEN))
OPDUALAG COMPONENT RELATLIMAB-RMBW
RELATLIMAB [INN]
RELATLIMAB [USAN]
RELATLIMAB [WHO-DD]
RELATLIMAB RMBW [WHO-DD]
RELATLIMAB-RMBW

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RELATLIMAB

Synonyms and Mappings

Resources